CAD 0.03
(0.0%)
Year | Net Income | Net Income Growth |
---|---|---|
2023 | -21.02 Million USD | 25.51% |
2022 | -28.22 Million USD | -1328.21% |
2021 | -1.97 Million USD | 57.02% |
2020 | -4.59 Million USD | 9.64% |
2019 | -5.08 Million USD | -185.73% |
2018 | -1.78 Million USD | -398.8% |
2017 | -357.06 Thousand USD | -178.29% |
2016 | 456.09 Thousand USD | 270.49% |
2015 | -267.51 Thousand USD | -0.21% |
2014 | -266.96 Thousand USD | 38.61% |
2013 | -434.88 Thousand USD | 65.89% |
2012 | -1.27 Million USD | -200.55% |
2011 | -424.17 Thousand USD | -159.09% |
2010 | -163.71 Thousand USD | -56.06% |
2009 | -104.9 Thousand USD | -24.47% |
2008 | -84.28 Thousand USD | 0.0% |
Year | Net Income | Net Income Growth |
---|---|---|
2024 Q2 | -253.83 Thousand USD | -401.66% |
2024 Q3 | -2.59 Million USD | -923.06% |
2024 Q1 | 84.14 Thousand USD | 100.74% |
2023 Q3 | -3.6 Million USD | -31.66% |
2023 FY | -21.02 Million USD | 25.51% |
2023 Q4 | -11.36 Million USD | -214.97% |
2023 Q1 | -2.95 Million USD | 86.8% |
2023 Q2 | -2.74 Million USD | 7.17% |
2022 Q2 | -2.87 Million USD | -264.58% |
2022 FY | -28.22 Million USD | -1328.21% |
2022 Q4 | -22.36 Million USD | -808.42% |
2022 Q3 | -2.46 Million USD | 14.42% |
2022 Q1 | -789.08 Thousand USD | -1084.15% |
2021 Q3 | -353.63 Thousand USD | 70.4% |
2021 Q4 | 80.18 Thousand USD | 122.67% |
2021 FY | -1.97 Million USD | 57.02% |
2021 Q1 | -792.54 Thousand USD | 24.65% |
2021 Q2 | -1.19 Million USD | -50.77% |
2020 Q1 | -896.79 Thousand USD | 48.26% |
2020 FY | -4.59 Million USD | 9.64% |
2020 Q4 | -1.05 Million USD | 9.06% |
2020 Q3 | -1.15 Million USD | 6.38% |
2020 Q2 | -1.23 Million USD | -37.75% |
2019 Q3 | -43.87 Thousand USD | 97.51% |
2019 Q4 | -1.73 Million USD | -3851.14% |
2019 FY | -5.08 Million USD | -185.73% |
2019 Q1 | -211.79 Thousand USD | -164.74% |
2019 Q2 | -1.76 Million USD | -732.73% |
2018 FY | -1.78 Million USD | -398.8% |
2018 Q4 | -80 Thousand USD | 71.54% |
2018 Q3 | -281.12 Thousand USD | 71.0% |
2018 Q2 | -969.42 Thousand USD | -115.19% |
2018 Q1 | -450.5 Thousand USD | -110.2% |
2017 Q2 | -32.77 Thousand USD | 58.42% |
2017 Q1 | -78.82 Thousand USD | -112.87% |
2017 Q4 | -214.32 Thousand USD | -588.15% |
2017 FY | -357.06 Thousand USD | -178.29% |
2017 Q3 | -31.14 Thousand USD | 4.98% |
2016 Q4 | 612.63 Thousand USD | 3255.29% |
2016 FY | 456.09 Thousand USD | 270.49% |
2016 Q2 | -41.06 Thousand USD | 57.25% |
2016 Q3 | -19.41 Thousand USD | 52.72% |
2016 Q1 | -96.06 Thousand USD | -23.24% |
2015 Q2 | -60.17 Thousand USD | 41.79% |
2015 Q4 | -77.94 Thousand USD | -199.33% |
2015 FY | -267.51 Thousand USD | -0.21% |
2015 Q1 | -103.36 Thousand USD | -1524.14% |
2015 Q3 | -26.04 Thousand USD | 56.72% |
2014 Q3 | -40.97 Thousand USD | 74.86% |
2014 FY | -266.96 Thousand USD | 38.61% |
2014 Q1 | -70.29 Thousand USD | 47.9% |
2014 Q2 | -162.96 Thousand USD | -131.83% |
2014 Q4 | 7258.00 USD | 117.72% |
2013 Q1 | -114.42 Thousand USD | 84.67% |
2013 FY | -434.88 Thousand USD | 65.89% |
2013 Q4 | -134.91 Thousand USD | -42.96% |
2013 Q3 | -94.37 Thousand USD | -3.51% |
2013 Q2 | -91.17 Thousand USD | 20.31% |
2012 FY | -1.27 Million USD | -200.55% |
2012 Q3 | -164.97 Thousand USD | 5.39% |
2012 Q2 | -174.37 Thousand USD | 7.7% |
2012 Q1 | -188.92 Thousand USD | 21.41% |
2012 Q4 | -746.61 Thousand USD | -352.56% |
2011 Q1 | -22.2 Thousand USD | 48.87% |
2011 FY | -424.17 Thousand USD | -159.09% |
2011 Q3 | -100.98 Thousand USD | -66.63% |
2011 Q2 | -60.6 Thousand USD | -172.92% |
2011 Q4 | -240.37 Thousand USD | -138.02% |
2010 Q4 | -43.43 Thousand USD | 24.22% |
2010 Q3 | -57.32 Thousand USD | -99.51% |
2010 FY | -163.71 Thousand USD | -56.06% |
2010 Q1 | -34.22 Thousand USD | -13.37% |
2010 Q2 | -28.73 Thousand USD | 16.06% |
2009 Q1 | -34.59 Thousand USD | 0.0% |
2009 Q4 | -30.19 Thousand USD | -6.46% |
2009 Q2 | -26.38 Thousand USD | 23.72% |
2009 Q3 | -28.36 Thousand USD | -7.47% |
2009 FY | -104.9 Thousand USD | -24.47% |
2008 FY | -84.28 Thousand USD | 0.0% |
Name | Net Income | Net Income Difference |
---|---|---|
Aion Therapeutic Inc. | -6.28 Million CAD | -234.433% |
Ayurcann Holdings Corp. | -3.96 Million CAD | -429.936% |
Blueberries Medical Corp. | -1.63 Million CAD | -1185.729% |
The BC Bud Corporation | -1.22 Million CAD | -1617.771% |
BioNxt Solutions Inc. | -7.72 Million CAD | -172.261% |
CordovaCann Corp. | -6.88 Million CAD | -205.41% |
Christina Lake Cannabis Corp. | -4.13 Million CAD | -408.891% |
Captor Capital Corp. | -11.38 Million CAD | -84.751% |
City View Green Holdings Inc. | -2.44 Million CAD | -758.717% |
1CM Inc. | -913.85 Thousand CAD | -2200.85% |
Global Hemp Group Inc. | -2.58 Million CAD | -714.811% |
Greenway Greenhouse Cannabis Corporation | -4.72 Million CAD | -345.225% |
IM Cannabis Corp. | -9.49 Million CAD | -121.378% |
Lobe Sciences Ltd. | -4.7 Million CAD | -346.674% |
Maple Leaf Green World Inc. | -1.09 Million CAD | -1826.336% |
Mountain Valley MD Holdings Inc. | -7.67 Million CAD | -174.139% |
Nextleaf Solutions Ltd. | 223.33 Thousand CAD | 9514.814% |
Ovation Science Inc. | -813.14 Thousand CAD | -2485.809% |
Pharmadrug Inc. | -13.2 Million CAD | -59.276% |
Captiva Verde Wellness Corp. | -6.08 Million CAD | -245.54% |
RAMM Pharma Corp. | -7.72 Million CAD | -172.332% |
RIV Capital Inc. | -106.76 Million CAD | 80.305% |
Revive Therapeutics Ltd. | -5.61 Million CAD | -274.228% |
Red White & Bloom Brands Inc. | -138.89 Million CAD | 84.862% |
SLANG Worldwide Inc. | -19.36 Million CAD | -8.573% |
1933 Industries Inc. | -13.36 Million CAD | -57.338% |
Red Light Holland Corp. | -7.62 Million CAD | -175.675% |
Top Strike Resources Corp. | -1.72 Million CAD | -1122.448% |
Xebra Brands Ltd. | -1.95 Million CAD | -974.216% |
Adastra Holdings Ltd. | -3.54 Million CAD | -493.191% |